March 28, 2014

Merck Animal Health receives marketing authorisation for chicken dewormer
 

Panacur^® AquaSol is a highly stable, farm-friendly, water-administered suspension product produced with new wet-milling technology. It is currently available in the European Economic Area (EEA) for use in swine.

"We are very pleased that the European Commission has approved Panacur^® AquaSol for chickens," stated Fabio Paganini, associate vice president, Merck Animal Health (known as MSD Animal Health outside the United States and Canada). "Panacur^® has a long history of proven results as a leading dewormer and we are excited to bring this option for convenient water administration to chicken farmers throughout the EEA," Paganini said.

Panacur^® AquaSol will be indicated for the treatment of gastro-intestinal nematodes in chickens infected with Ascaridia galli (L5 and adult stages) and Heterakis gallinarum (L5 and adult stages).

Through the company's proprietary wet-milling technology, Panacur^® AquaSol is a highly stable suspension which, as a result of smaller and more uniform particle size, does not require frequent agitation and provides a high level of efficacy and convenience.

Panacur^® AquaSol has been proven safe for all types of chicken, including layers, broilers and breeders. It has a zero-day withdrawal period for eggs and a six-day withdrawal period for meat and offal.

"Managing intestinal health properly results in better overall performance for layers, broilers and breeders alike," explained Rik Koopman, director, scientific affairs, Merck Animal Health. "If not managed with proper parasite control, farmers could experience an economic impact when there is a drop in production or a loss due to worm infestation," Koopman said.

MSD Animal Health offers veterinarians, farmers, pet owners and governments one of the widest range of veterinary pharmaceuticals, vaccines and health management solutions and services.